Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance

Guardado en:

Detalles Bibliográficos
Autores principales:	Masarret Fazili, Scott M. Stevens, Scott C. Woller
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2020
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/19588b5652a247dfaf9921b1cf187c33
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:19588b5652a247dfaf9921b1cf187c33
record_format	dspace
spelling	oai:doaj.org-article:19588b5652a247dfaf9921b1cf187c332021-11-15T06:10:43ZDirect oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance2475-037910.1002/rth2.12287https://doaj.org/article/19588b5652a247dfaf9921b1cf187c332020-01-01T00:00:00Zhttps://doi.org/10.1002/rth2.12287https://doaj.org/toc/2475-0379Masarret FaziliScott M. StevensScott C. WollerWileyarticleDiseases of the blood and blood-forming organsRC633-647.5ENResearch and Practice in Thrombosis and Haemostasis, Vol 4, Iss 1, Pp 9-12 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the blood and blood-forming organs RC633-647.5
spellingShingle	Diseases of the blood and blood-forming organs RC633-647.5 Masarret Fazili Scott M. Stevens Scott C. Woller Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
format	article
author	Masarret Fazili Scott M. Stevens Scott C. Woller
author_facet	Masarret Fazili Scott M. Stevens Scott C. Woller
author_sort	Masarret Fazili
title	Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
title_short	Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
title_full	Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
title_fullStr	Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
title_full_unstemmed	Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
title_sort	direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: impact of the european medicines agency guidance
publisher	Wiley
publishDate	2020
url	https://doaj.org/article/19588b5652a247dfaf9921b1cf187c33
work_keys_str_mv	AT masarretfazili directoralanticoagulantsinantiphospholipidsyndromewithvenousthromboembolismimpactoftheeuropeanmedicinesagencyguidance AT scottmstevens directoralanticoagulantsinantiphospholipidsyndromewithvenousthromboembolismimpactoftheeuropeanmedicinesagencyguidance AT scottcwoller directoralanticoagulantsinantiphospholipidsyndromewithvenousthromboembolismimpactoftheeuropeanmedicinesagencyguidance
_version_	1718428537762873344

Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance

Ejemplares similares